Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research

Pfizer, Merck Q4 earnings: A breakdown of the pharma stocks

February 04, 2025 05:36 PM GMT | By EODHD
Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
Pfizer, Merck Q4 earnings: A breakdown of the pharma stocks
Image source: Kalkine Media

Recent News

thumbnail

International African Energy, Oil & Gas Summit (IAEOGS) 2025 Set for A...

thumbnail

Global Immigration Partners Named Immigration Law Firm of the Year – U...

thumbnail

Silicone Resins Market Set for Steady Growth, Reaching USD 1.72 Billio...

thumbnail

Maxiforce Expands Operations into England, Delivering Reliable Diesel...

Earnings are painting a mixed picture within the pharmaceutical space Tuesday morning, as Merck (MRK) and Pfizer (PFE) reported their fourth quarter results. Yahoo Finance senior health reporter Anjalee Khemlani joins Morning Brief hosts Seana Smith and Brad Smith to break down the performance of the two pharma stocks, citing Merck's weak guidance and Gardisil oversupply in China, while outlining Pfizer's earnings and revenue beats and 2025 outlook. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Josh Lynch 相關影片 01:00 Disney earnings, Fed commentary, ADP data: What to Watch Yahoo Finance Video • 3 hours ago 02:49 Alphabet reverses ban on AI use for weapons, following Palantir Yahoo Finance Video • 4 hours ago 03:25 AMD, Alphabet fall after Q4 results: Biggest earnings takeaways Yahoo Finance Video • 4 hours ago 03:24 Why AMD is 'the best alternative' to Nvidia Yahoo Finance Video • 5 hours ago 查看留言

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

UK_Premium_Article

Sponsored Articles

1

Union Jack Oil (LON:UJO) reports strong financials for 1H with £2MM ma...

2

A view of how UK’s lottery industry is embracing internet

3

Launch of Game Changing Silumina Anodes

4

Altech Chemicals launches its trademark “Silumina Anodes” name for its...

5

Reabold (LON: RBD) moving on the right track on West Newton Project

Investing Ideas

Previous Next